306 related articles for article (PubMed ID: 29733876)
1. Magnetically driven drug delivery systems improving targeted immunotherapy for colon-rectal cancer.
Grifantini R; Taranta M; Gherardini L; Naldi I; Parri M; Grandi A; Giannetti A; Tombelli S; Lucarini G; Ricotti L; Campagnoli S; De Camilli E; Pelosi G; Baldini F; Menciassi A; Viale G; Pileri P; Cinti C
J Control Release; 2018 Jun; 280():76-86. PubMed ID: 29733876
[TBL] [Abstract][Full Text] [Related]
2. FAT1: a potential target for monoclonal antibody therapy in colon cancer.
Pileri P; Campagnoli S; Grandi A; Parri M; De Camilli E; Song C; Ganfini L; Lacombe A; Naldi I; Sarmientos P; Cinti C; Jin B; Grandi G; Viale G; Terracciano L; Grifantini R
Br J Cancer; 2016 Jun; 115(1):40-51. PubMed ID: 27328312
[TBL] [Abstract][Full Text] [Related]
3. Negatively charged AuNP modified with monoclonal antibody against novel tumor antigen FAT1 for tumor targeting.
Fan L; Campagnoli S; Wu H; Grandi A; Parri M; De Camilli E; Grandi G; Viale G; Pileri P; Grifantini R; Song C; Jin B
J Exp Clin Cancer Res; 2015 Sep; 34(1):103. PubMed ID: 26373379
[TBL] [Abstract][Full Text] [Related]
4. Newly engineered magnetic erythrocytes for sustained and targeted delivery of anti-cancer therapeutic compounds.
Cinti C; Taranta M; Naldi I; Grimaldi S
PLoS One; 2011 Feb; 6(2):e17132. PubMed ID: 21373641
[TBL] [Abstract][Full Text] [Related]
5. Insight to drug delivery aspects for colorectal cancer.
Gulbake A; Jain A; Jain A; Jain A; Jain SK
World J Gastroenterol; 2016 Jan; 22(2):582-99. PubMed ID: 26811609
[TBL] [Abstract][Full Text] [Related]
6. Polymeric nanocarriers for magnetic targeted drug delivery: preparation, characterization, and in vitro and in vivo evaluation.
Licciardi M; Scialabba C; Fiorica C; Cavallaro G; Cassata G; Giammona G
Mol Pharm; 2013 Dec; 10(12):4397-407. PubMed ID: 24168360
[TBL] [Abstract][Full Text] [Related]
7. Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer.
Zalba S; Contreras AM; Haeri A; Ten Hagen TL; Navarro I; Koning G; Garrido MJ
J Control Release; 2015 Jul; 210():26-38. PubMed ID: 25998052
[TBL] [Abstract][Full Text] [Related]
8. Integrinβ6-targeted immunoliposomes mediate tumor-specific drug delivery and enhance therapeutic efficacy in colon carcinoma.
Liang B; Shahbaz M; Wang Y; Gao H; Fang R; Niu Z; Liu S; Wang B; Sun Q; Niu W; Liu E; Wang J; Niu J
Clin Cancer Res; 2015 Mar; 21(5):1183-95. PubMed ID: 25549721
[TBL] [Abstract][Full Text] [Related]
9. Magnetically assisted intraperitoneal drug delivery for cancer chemotherapy.
Shamsi M; Sedaghatkish A; Dejam M; Saghafian M; Mohammadi M; Sanati-Nezhad A
Drug Deliv; 2018 Nov; 25(1):846-861. PubMed ID: 29589479
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable polyelectrolyte/magnetite capsules for MR imaging and magnetic targeting of tumors.
Svenskaya Y; Garello F; Lengert E; Kozlova A; Verkhovskii R; Bitonto V; Ruggiero MR; German S; Gorin D; Terreno E
Nanotheranostics; 2021; 5(3):362-377. PubMed ID: 33850694
[No Abstract] [Full Text] [Related]
11. The possibility of using magnetic nanoparticles to increase the therapeutic efficiency of Herceptin antibody.
Rasaneh S; Dadras MR
Biomed Tech (Berl); 2015 Oct; 60(5):485-90. PubMed ID: 26146093
[TBL] [Abstract][Full Text] [Related]
12. Erythro-Magneto-HA-Virosome: A Bio-Inspired Drug Delivery System for Active Targeting of Drugs in the Lungs.
Vizzoca A; Lucarini G; Tognoni E; Tognarelli S; Ricotti L; Gherardini L; Pelosi G; Pellegrino M; Menciassi A; Grimaldi S; Cinti C
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077300
[TBL] [Abstract][Full Text] [Related]
13. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
14. Targeting Colorectal Cancer Stem-Like Cells with Anti-CD133 Antibody-Conjugated SN-38 Nanoparticles.
Ning ST; Lee SY; Wei MF; Peng CL; Lin SY; Tsai MH; Lee PC; Shih YH; Lin CY; Luo TY; Shieh MJ
ACS Appl Mater Interfaces; 2016 Jul; 8(28):17793-804. PubMed ID: 27348241
[TBL] [Abstract][Full Text] [Related]
15. Targeted immunotherapy for colorectal cancer: monoclonal antibodies and immunotoxins.
Shapira S; Lisiansky V; Arber N; Kraus S
Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S67-77. PubMed ID: 20374033
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticles for Colorectal Cancer Targeted Drug Delivery and MR Imaging: Current Situation and Perspectives.
Dong Z; Cui MY; Peng Z; Li Y; Wang X; Fang Z; Jiang M; Xu L; Luo Y; Li ZP; Feng ST
Curr Cancer Drug Targets; 2016; 16(6):536-50. PubMed ID: 26632434
[TBL] [Abstract][Full Text] [Related]
17. Magnetically guided targeted delivery of erythropoietin using magnetic nanoparticles: Proof of concept.
Nguyen CT; Kim CR; Le TH; Koo KI; Hwang CH
Medicine (Baltimore); 2020 May; 99(19):e19972. PubMed ID: 32384447
[TBL] [Abstract][Full Text] [Related]
18. Targeted nanoparticles for colorectal cancer.
Cisterna BA; Kamaly N; Choi WI; Tavakkoli A; Farokhzad OC; Vilos C
Nanomedicine (Lond); 2016 Sep; 11(18):2443-56. PubMed ID: 27529192
[TBL] [Abstract][Full Text] [Related]
19. Magnetic polycarbonate microspheres for tumor-targeted delivery of tumor necrosis factor.
Hu B; Du HJ; Yan GP; Zhuo RX; Wu Y; Fan CL
Drug Deliv; 2014 May; 21(3):204-12. PubMed ID: 24117028
[TBL] [Abstract][Full Text] [Related]
20. EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer.
Li Y; Duo Y; Bao S; He L; Ling K; Luo J; Zhang Y; Huang H; Zhang H; Yu X
Int J Nanomedicine; 2017; 12():6239-6257. PubMed ID: 28894364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
